Firm will be in charge of sales, service, and support for most countries outside the U.S. Roche and PerkinElmer inked a supply agreement for distribution of the NimbleGen CGX microarray workflow for ...
MADISON, Wis. & WALTHAM, Mass.--(BUSINESS WIRE)-- Roche (SIX: RO, ROG; OTCQX: RHHBY) and PerkinElmer (NYSE: PKI) today announced a new supply agreement for distribution of the NimbleGen CGX microarray ...
MADISON, Wis.--(BUSINESS WIRE)--Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The highly ...
EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® ...
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ — AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac Disease ...
Roche and PerkinElmer have announced a new supply agreement for distribution of the NimbleGen CGX microarray workflow, for use in constitutional disease research. Under this agreement, effective ...
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback